Role of Vitamin D Receptor in the Regulation of Gene Expression

Overview

Journal Acta Pharm Sin B

Publisher Elsevier

Specialty Pharmacology

Date 2019 Dec 24

PMID 31867158

Citations 23

Authors

Xuan Qin

Xin Wang

Affiliations

Soon will be listed here.

Abstract

Vitamin D (VD) is a multifunctional nutrient which can be either synthesized or absorbed from the diet. It plays a pivotal role in systemic calcium and phosphate homeostasis, as well as in various physiological and pathological processes. VD is converted to the active form, 1,25-dihydroxyvitamin D (1,25-D3), by cytochrome P450 2R1 (CYP2R1)/CYP27A1 and CYP27B1 sequentially, and deactivated by multiple enzymes including CYP3A4. On the other hand, 1,25-D3 is capable of activating the transcription of genes in humans, mice and rats. The vitamin D receptor (VDR)-mediated transactivation of human and resembles that known for pregnane X receptor (PXR). Activated VDR forms a heterodimer with retinoid X receptor (RXR), recruits co-activators, translocates to the cell nucleus, binds to the specific vitamin D responsive elements (VDRE), and activates the gene transcription. In mice, intestinal mRNA levels, but not those of hepatic CYP3As, were induced by administration of VDR and PXR agonists. In rats, intestinal and mRNAs were induced by 1,25-D3 or lithocholic acid (LCA), whereas hepatic , but not and , was modulated to 1,25-D3 treatment. In general, the VDR-mediated regulation of CYP3A presents species and organ specificity.

Citing Articles

CYP3A4 and CYP3A5: the crucial roles in clinical drug metabolism and the significant implications of genetic polymorphisms.

Zhang Y, Wang Z, Wang Y, Jin W, Zhang Z, Jin L PeerJ. 2024; 12:e18636.

PMID: 39650550 PMC: 11625447. DOI: 10.7717/peerj.18636.

The Role of Vitamin D Metabolism Genes and Their Genomic Background in Shaping Cyclosporine A Dosage Parameters after Kidney Transplantation.

Kotowska K, Wojciuk B, Sienko J, Bogacz A, Stukan I, Drozdzal S J Clin Med. 2024; 13(16).

PMID: 39201108 PMC: 11355102. DOI: 10.3390/jcm13164966.

VDR promotes pancreatic cancer progression in vivo by activating CCL20-mediated M2 polarization of tumor associated macrophage.

Li H, Ruan Y, Liu C, Fan X, Yao Y, Dai Y Cell Commun Signal. 2024; 22(1):224.

PMID: 38600588 PMC: 11005177. DOI: 10.1186/s12964-024-01578-x.

Gut liver brain axis in diseases: the implications for therapeutic interventions.

Yan M, Man S, Sun B, Ma L, Guo L, Huang L Signal Transduct Target Ther. 2023; 8(1):443.

PMID: 38057297 PMC: 10700720. DOI: 10.1038/s41392-023-01673-4.

Metabolic and Genetic Association of Vitamin D with Calcium Signaling and Insulin Resistance.

Tarfeen N, Ul Nisa K, Ahmad M, Waza A, Ganai B Indian J Clin Biochem. 2023; 38(4):407-417.

PMID: 37746541 PMC: 10516840. DOI: 10.1007/s12291-022-01105-0.

References

Zierold C, Mings J, Deluca H . 19nor-1,25-dihydroxyvitamin D2 specifically induces CYP3A9 in rat intestine more strongly than 1,25-dihydroxyvitamin D3 in vivo and in vitro. Mol Pharmacol. 2006; 69(5):1740-7. DOI: 10.1124/mol.105.019851. View

Dou R, Ng K, Giovannucci E, Manson J, Qian Z, Ogino S . Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence. Br J Nutr. 2016; 115(9):1643-60. PMC: 4890569. DOI: 10.1017/S0007114516000696. View

Yasunami Y, Hara H, Iwamura T, Kataoka T, Adachi T . C-jun N-terminal kinase modulates 1,25-dihydroxyvitamin D3-induced cytochrome P450 3A4 gene expression. Drug Metab Dispos. 2004; 32(7):685-8. DOI: 10.1124/dmd.32.7.685. View

Qin X, Liu M, Wang X . New insights into the androgen biotransformation in prostate cancer: A regulatory network among androgen, androgen receptors and UGTs. Pharmacol Res. 2016; 106:114-122. DOI: 10.1016/j.phrs.2016.02.021. View

Maguire O, Pollock C, Martin P, Owen A, Smyth T, Doherty D . Regulation of CYP3A4 and CYP3A5 expression and modulation of "intracrine" metabolism of androgens in prostate cells by liganded vitamin D receptor. Mol Cell Endocrinol. 2012; 364(1-2):54-64. DOI: 10.1016/j.mce.2012.08.007. View

Matsubara T, Kim H, Miyata M, Shimada M, Nagata K, Yamazoe Y . Isolation and characterization of a new major intestinal CYP3A form, CYP3A62, in the rat. J Pharmacol Exp Ther. 2004; 309(3):1282-90. DOI: 10.1124/jpet.103.061671. View

Thirumaran R, Lamba J, Kim R, Urquhart B, Gregor J, Chande N . Intestinal CYP3A4 and midazolam disposition in vivo associate with VDR polymorphisms and show seasonal variation. Biochem Pharmacol. 2012; 84(1):104-12. PMC: 3774043. DOI: 10.1016/j.bcp.2012.03.017. View

Zhou H, Hylemon P . Bile acids are nutrient signaling hormones. Steroids. 2014; 86:62-8. PMC: 4073476. DOI: 10.1016/j.steroids.2014.04.016. View

Martinez-Jimenez C, Jover R, Donato M, Castell J, Gomez-Lechon M . Transcriptional regulation and expression of CYP3A4 in hepatocytes. Curr Drug Metab. 2007; 8(2):185-94. DOI: 10.2174/138920007779815986. View

10.

Zhang L, Wang S, Che X, Li X . Vitamin D and lung cancer risk: a comprehensive review and meta-analysis. Cell Physiol Biochem. 2015; 36(1):299-305. DOI: 10.1159/000374072. View

11.

Maglich J, Stoltz C, Goodwin B, Hawkins-Brown D, Moore J, Kliewer S . Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol. 2002; 62(3):638-46. DOI: 10.1124/mol.62.3.638. View

12.

Fan J, Maeng H, Du Y, Kwan D, Pang K . Transport of 5,5-diphenylbarbituric acid and its precursors and their effect on P-gp, MRP2 and CYP3A4 in Caco-2 and LS180 cells. Eur J Pharm Sci. 2010; 42(1-2):19-29. DOI: 10.1016/j.ejps.2010.10.001. View

13.

Zanger U, Schwab M . Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013; 138(1):103-41. DOI: 10.1016/j.pharmthera.2012.12.007. View

14.

Komura H, Iwaki M . In vitro and in vivo small intestinal metabolism of CYP3A and UGT substrates in preclinical animals species and humans: species differences. Drug Metab Rev. 2011; 43(4):476-98. DOI: 10.3109/03602532.2011.597401. View

15.

Meyer R, Gehlhaus M, Schwab R, Burck C, Knoth R, Hagemeyer C . Concordant up-regulation of cytochrome P450 Cyp3a11, testosterone oxidation and androgen receptor expression in mouse brain after xenobiotic treatment. J Neurochem. 2009; 109(2):670-81. DOI: 10.1111/j.1471-4159.2009.05994.x. View

16.

Wang H, Negishi M . Transcriptional regulation of cytochrome p450 2B genes by nuclear receptors. Curr Drug Metab. 2003; 4(6):515-25. DOI: 10.2174/1389200033489262. View

17.

Lu J, Shao Y, Qin X, Liu D, Chen A, Li D . CRISPR knockout rat cytochrome P450 3A1/2 model for advancing drug metabolism and pharmacokinetics research. Sci Rep. 2017; 7:42922. PMC: 5317174. DOI: 10.1038/srep42922. View

18.

Mozos I, Marginean O . Links between Vitamin D Deficiency and Cardiovascular Diseases. Biomed Res Int. 2015; 2015:109275. PMC: 4427096. DOI: 10.1155/2015/109275. View

19.

Matsubara T, Yoshinari K, Aoyama K, Sugawara M, Sekiya Y, Nagata K . Role of vitamin D receptor in the lithocholic acid-mediated CYP3A induction in vitro and in vivo. Drug Metab Dispos. 2008; 36(10):2058-63. DOI: 10.1124/dmd.108.021501. View

20.

Chow E, Sondervan M, Jin C, Groothuis G, Pang K . Comparative effects of doxercalciferol (1α-hydroxyvitamin D₂) versus calcitriol (1α,25-dihydroxyvitamin D₃) on the expression of transporters and enzymes in the rat in vivo. J Pharm Sci. 2010; 100(4):1594-604. DOI: 10.1002/jps.22366. View